In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...

Comprehensive Arthritis and Lupus Care in Conway Conway, United States – December 21, 2025 / Noydeen Medial / In Conway, Arkansas, Noydeen Medical Group is proud to announce the expansion of its ...

Cambridge: AstraZeneca has announced that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

#Melatonin & #Lupus Research: A new review stresses the need for standardized sampling protocols due to the fluctuation of melatonin levels with circadian rhythms. Future studies must explore ...

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...

Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion AstraZeneca's Saphnelo (anifrolumab) has been approved in the European Union (EU ...

The Global Healthy Living Foundation (GHLF) today announced a success milestone for its Spanish-Language Lupus Resource Center, a sister program to its widely used English-language Lupus Help Center.

Half of the world's population will go through menopause, and more women are spreading awareness about this life stage.

Nearly 1 in 4 Americans believe the U.S. health care system is in crisis, and high costs are the top reason why, the results ...

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to ...